Cargando…

Identifying therapeutic targets for schizophrenia

There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...

Descripción completa

Detalles Bibliográficos
Autor principal:	Montague-Cardoso, Karli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192517/ https://www.ncbi.nlm.nih.gov/pubmed/34112930 http://dx.doi.org/10.1038/s42003-021-02270-3

Ejemplares similares

Teasing apart the cell death pathways in HIV pathogenesis
por: Montague-Cardoso, Karli
Publicado: (2021)

Cellular proteostasis decline in human senescence
por: Montague-Cardoso, Karli
Publicado: (2021)

T cells in the brain may contribute to attenuation of sepsis-associated depression
por: Montague-Cardoso, Karli
Publicado: (2021)

Beta-amyloid production in neurons is regulated by astrocyte-derived cholesterol
por: Montague-Cardoso, Karli
Publicado: (2021)

Sleep-wake cycles are disrupted by diseases that result in cytoplasmic crowding
por: Montague-Cardoso, Karli
Publicado: (2020)

OPCs eat in response to sensory experiences
por: Montague-Cardoso, Karli
Publicado: (2022)

A DNA origami-based nanoscale molecular transport railway
por: Lim, Theam Soon, et al.
Publicado: (2021)

Glycans housed by a bacteriophage enable rapid identification of glycan recognition patterns
por: Lim, Theam Soon, et al.
Publicado: (2021)

Cathepsin S as a potential therapeutic target for chronic pain
por: Montague-Cardoso, Karli, et al.
Publicado: (2020)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain
por: Montague, Karli, et al.
Publicado: (2017)

ASGR1: an emerging therapeutic target in hypercholesterolemia
por: Zhao, Wenqi, et al.
Publicado: (2023)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
por: Zhang, Yun, et al.
Publicado: (2020)

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
por: Zhao, Yingjun, et al.
Publicado: (2022)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

LARGE enzyme activity deciphered: a new therapeutic target for muscular dystrophies
por: Hewitt, Jane E
Publicado: (2012)

The cGAS-STING pathway: a therapeutic target in chromosomally unstable cancers
por: Yan, Haiyan, et al.
Publicado: (2023)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis
por: Wang, Manni, et al.
Publicado: (2021)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
por: Fu, Caiyun
Publicado: (2020)

Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target
por: Abdallah, Mohamed A., et al.
Publicado: (2020)

Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
por: Weiskirchen, Ralf
Publicado: (2023)

Crucial timing in schizophrenia: role of DNA methylation in early neurodevelopment
por: Ryan, Joanne, et al.
Publicado: (2014)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target
por: Giovannoni, Federico, et al.
Publicado: (2020)

Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets
por: Diao, Xiayao, et al.
Publicado: (2022)

Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
por: Schwartz, Zander, et al.
Publicado: (2022)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Step further towards targeted senolytic therapy: therapeutic potential of uPAR-CAR T cells for senescence-related diseases
por: Huang, Yujia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tjntnndmu8egdm33mg2hikconn